Cleared Traditional

K142421 - G-scan Brio

K142421 is the FDA 510(k) clearance for G-scan Brio by Esaote, S.P.A.. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 224-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2015
Decision
224d
Days
Class 2
Risk

K142421 is an FDA 510(k) clearance for the G-scan Brio. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Esaote, S.P.A. (Genova, IT). The FDA issued a Cleared decision on April 9, 2015 after a review of 224 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Esaote, S.P.A. devices

Submission Details

510(k) Number K142421 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2014
Decision Date April 09, 2015
Days to Decision 224 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 107d · This submission: 224d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Navigant Consulting, Inc.
Allison Scott

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 817
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K142421.
S-scan
K151668 · Esaote, S.P.A. · Sep 2015
ECHELON Oval V 5.0 MRI System
K151015 · Hitachi Medical Systems America, Inc. · Jul 2015
Vantage Titan 1.5T, V3.1, MRT-1510
K150427 · Toshibamedical Systems Corporation · Apr 2015
Vantage Titan 3T
K143008 · Toshibamedical Systems Corporation · Apr 2015
O-MAR
K143253 · Philips Medical Systems Nederland B.V. · Apr 2015
TRILLIUM Oval MR System
K142734 · Hitachi Medical Systems America, Inc. · Mar 2015